Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

76.84
Delayed Data
As of 4:01pm ET
 -0.69 / -0.89%
Today’s Change
64.18
Today|||52-Week Range
84.80
+4.47%
Year-to-Date
Here's Why CoLucid Pharmaceuticals Inc Popped Yesterday
2:54pm / MotleyFool.com - Paid Partner Content
Why Fastenal, Mead Johnson Nutrition, and CoLucid Pharmaceuticals Jumped Today
Jan 18 / MotleyFool.com - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
9:21am / Zacks.com - Paid Partner Content
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
9:21am / Zacks.com - Paid Partner Content
Stocks Struggle for Direction as Economic Improvements May Push Fed Moves
Jan 18 / TheStreet.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
9:21am / Zacks.com - Paid Partner Content
What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?
Jan 18 / Zacks.com - Paid Partner Content
Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout
9:21am / Zacks.com - Paid Partner Content
Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
Jan 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close77.53
Today’s open77.47
Day’s range76.76 - 77.62
Volume4,438,986
Average volume (3 months)5,412,916
Market cap$85.6B
Dividend yield2.71%
Data as of 4:01pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+3.31%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+1.75%
P/E ratio33.4
Price/Sales4.50
Price/Book5.88

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.60-1.39%
AGNAllergan-1.98-0.91%
BMYBristol-Myers Squibb-0.58-1.03%
GSKGlaxoSmithKline-0.14-0.36%
Data as of 4:02pm ET, 01/19/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.98
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs